Age and Acute Myeloid Leukaemia: A Study of Cytogenetic Subtypes
Author Information
Author(s): Moorman A V, Roman E, Cartwright R A, Morgan G J
Primary Institution: Leukaemia Research Fund Centre for Clinical Epidemiology, University of Leeds
Hypothesis
Does the incidence of cytogenetically-defined subtypes of acute myeloid leukaemia vary with age?
Conclusion
The incidence of acute myeloid leukaemia increases with age, but certain subtypes, particularly those with translocations, do not show this trend.
Supporting Evidence
- The incidence of de novo AML increased with age, rising from <10 per million among those aged 16–29 years to >40 per million among those aged 60–69 years.
- Translocation-positive AML showed a constant incidence across different age groups.
- Age distribution profiles for AML patients with certain chromosomal abnormalities were reported in previous studies.
Takeaway
As people get older, more of them get acute myeloid leukaemia, but some types of it don't seem to be affected by age at all.
Methodology
The study analyzed cases of de novo acute myeloid leukaemia from a population-based case-control study over five years, focusing on cytogenetic data.
Limitations
The study is limited to cases with pathologically confirmed diagnoses and may not represent all AML cases.
Participant Demographics
Adults aged 16–69 years diagnosed with acute leukaemia.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website